Home/Filings/4/0001104659-25-022257
4//SEC Filing

Maraoui Claude 4

Accession 0001104659-25-022257

CIK 0001867066other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 6:21 PM ET

Size

8.8 KB

Accession

0001104659-25-022257

Insider Transaction Report

Form 4
Period: 2025-03-06
Maraoui Claude
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2025-03-06$5.04/sh25,551$128,7772,067,323 total
  • Sale

    Common Stock, $0.0001 par value

    2025-03-07$5.01/sh14,905$74,6742,052,418 total
Footnotes (5)
  • [F1]In connection with the vesting of restricted stock units which vested as of various dates, a total of 25,551 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
  • [F2]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 6, 2025, was $5.00 to $5.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Includes restricted stock units, which vest over various time periods.
  • [F4]In connection with the vesting of restricted stock units which vested as of various dates, a total of 14,905 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
  • [F5]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 7, 2025, was $4.99 to $5.14. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.

Issuer

Journey Medical Corp

CIK 0001867066

Entity typeother

Related Parties

1
  • filerCIK 0001893880

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 6:21 PM ET
Size
8.8 KB